Thalys Medical Technology Group Corporation (SHA:603716)
China flag China · Delayed Price · Currency is CNY
23.32
-0.58 (-2.43%)
Mar 10, 2026, 9:35 AM CST

SHA:603716 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Operating Revenue
1,2431,8061,9922,2932,5902,124
Upgrade
Other Revenue
5.145.1414.5316.059.991.49
Upgrade
Revenue
1,2481,8112,0062,3092,6002,125
Upgrade
Revenue Growth (YoY)
-34.22%-9.74%-13.10%-11.19%22.30%16.10%
Upgrade
Cost of Revenue
1,0151,4821,6161,8602,0571,639
Upgrade
Gross Profit
232.42328.54389.74448.96542.74486.83
Upgrade
Selling, General & Admin
261.55299.75327.98336.23339.89260.99
Upgrade
Research & Development
44.8846.5343.0229.3235.4719.49
Upgrade
Other Operating Expenses
8.717.919.4810.712.619.87
Upgrade
Operating Expenses
316.86315.66408.65464.47447.93312.52
Upgrade
Operating Income
-84.4412.88-18.91-15.5194.81174.31
Upgrade
Interest Expense
-41.76-57.68-76.19-98.76-82.78-57.72
Upgrade
Interest & Investment Income
6.473.847.5119.367.9510.98
Upgrade
Currency Exchange Gain (Loss)
-0.55-0.55-3.04-7.620.4-0.22
Upgrade
Other Non Operating Income (Expenses)
-4.68-5.38-52.67-5.37-18.36-14.89
Upgrade
EBT Excluding Unusual Items
-124.96-46.89-143.3-107.892.03112.46
Upgrade
Impairment of Goodwill
-22.43-22.43-26.61-12.23--0.01
Upgrade
Gain (Loss) on Sale of Investments
-20.43-68.01-11.3-31.8-25.66-
Upgrade
Gain (Loss) on Sale of Assets
-8.78-9.37-11.83-0.020.4-0.16
Upgrade
Asset Writedown
-0.3---6.95-0.72-0.46
Upgrade
Other Unusual Items
-1.47-1.590.54-32.82-0.15-3.75
Upgrade
Pretax Income
-178.36-148.3-192.5-191.71-24.11108.08
Upgrade
Income Tax Expense
60.6745.09-35.73-1.4614.2726.05
Upgrade
Earnings From Continuing Operations
-239.03-193.39-156.78-190.25-38.3882.03
Upgrade
Minority Interest in Earnings
-1.43-15.85-1.836.52-11.13-24.47
Upgrade
Net Income
-240.46-209.24-158.57-153.73-49.5157.56
Upgrade
Net Income to Common
-240.46-209.24-158.57-153.73-49.5157.56
Upgrade
Net Income Growth
------47.87%
Upgrade
Shares Outstanding (Basic)
191192193195198198
Upgrade
Shares Outstanding (Diluted)
191192193195198198
Upgrade
Shares Change (YoY)
-4.89%-0.73%-0.62%-1.73%-0.23%0.66%
Upgrade
EPS (Basic)
-1.26-1.09-0.82-0.79-0.250.29
Upgrade
EPS (Diluted)
-1.26-1.09-0.82-0.79-0.250.29
Upgrade
EPS Growth
------48.21%
Upgrade
Free Cash Flow
59.7776.3985.06-26.52-193.71-117.76
Upgrade
Free Cash Flow Per Share
0.310.400.44-0.14-0.98-0.59
Upgrade
Gross Margin
18.63%18.14%19.43%19.45%20.88%22.91%
Upgrade
Operating Margin
-6.77%0.71%-0.94%-0.67%3.65%8.20%
Upgrade
Profit Margin
-19.27%-11.56%-7.90%-6.66%-1.90%2.71%
Upgrade
Free Cash Flow Margin
4.79%4.22%4.24%-1.15%-7.45%-5.54%
Upgrade
EBITDA
-63.5747.333.5845.23166.83250.9
Upgrade
EBITDA Margin
-5.10%2.61%1.67%1.96%6.42%11.80%
Upgrade
D&A For EBITDA
20.8734.4252.560.7472.0176.59
Upgrade
EBIT
-84.4412.88-18.91-15.5194.81174.31
Upgrade
EBIT Margin
-6.77%0.71%-0.94%-0.67%3.65%8.20%
Upgrade
Effective Tax Rate
-----24.10%
Upgrade
Revenue as Reported
1,2481,8112,0062,3092,6002,125
Upgrade
Advertising Expenses
----12.895.43
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.